UPDATE : Friday, October 18, 2019
상단여백
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo  |  2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo  |  2019-10-18 16:48
라인
Medytox exported ₩3.3 billion worth of unqualified BTX
The Ministry of Food and Drug Safety ordered Medytox to recall and discard ...
by Jeong Sae-im  |  2019-10-18 16:02
라인
Daewoong launches BTX in Canada
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX)...
by Lee Han-soo  |  2019-10-18 14:31
라인
Korea still has highest TB incidence, mortality in OECD
Despite the government’s anti-tuberculosis efforts, Korea still suffered th...
by Kwak Sung-sun  |  2019-10-18 14:31
라인
[Startups to Watch] 'Vuno puts doctors’ needs ahead of marketability in developing products’
The rise of artificial intelligence (AI) has thrown pharmaceutical companie...
by Lee Han-soo  |  2019-10-18 12:21
라인
Regulator cautions investors against betting on biotech shares
The Financial Services Commission (FSC) issued a warning on retail investor...
by Kwak Sung-sun  |  2019-10-18 11:09
라인
Severance researchers find intestinal inflammatory inhibition gene
Researchers at Severance Hospital have discovered RORα, a new gene th...
by Lee Han-soo  |  2019-10-17 18:00
라인
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
CHA Biotech said it has registered a patent for the method of manufacturing...
by Lee Han-soo  |  2019-10-17 17:59
라인
[Special] When will Koreans start using digital therapeutics?
Digital therapeutics can be classified as medicine and non-medicine at the ...
by Park Gi-taek  |  2019-10-17 16:06
라인
‘Inventage Lab’s hair loss injection more convenient than oral drugs’
Researchers at Chung-Ang University Hospital have confirmed the efficacy of...
by Lee Han-soo  |  2019-10-17 14:48
라인
US sales of Remicade drop due to biosimilar’s rise
U.S. sales of Remicade (ingredient: infliximab), the autoimmune disease tre...
by Jeong Sae-im  |  2019-10-17 13:32
라인
65% of gastroenterologists show burnout symptoms
Korean gastroenterologists were suffering from a high level of burnout, a s...
by Choi Gwang-seok  |  2019-10-17 11:19
라인
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
Eisai's Lenvima, a hepatocellular carcinoma treatment, has managed to s...
by Lee Han-soo  |  2019-10-16 18:22
라인
Foreign patients receiving plastic surgery hit record high in 2018
The number of foreign patients visiting Korea increased last year, and the ...
by Kwak Sung-sun  |  2019-10-16 15:28
라인
‘New drug approval process takes about 300 days in Korea’
A local research team has found that it takes about 300 days for multinatio...
by Lee Han-soo  |  2019-10-16 15:06
라인
State organs squandered ₩8.2 billion; failed to spot Invossa problem
The government invested 8.21 billion won ($6.9 million) in healthcare-relat...
by Kwak Sung-sun  |  2019-10-16 15:06
라인
[Exclusive] Samsung admits it failed to develop Rituxan biosimilar
The Samsung Group has admitted that a Samsung-affiliated company failed to ...
by Jeong Sae-im  |  2019-10-16 14:16
라인
Eulji Medical Center transfers advanced medical expertise to Bangladesh
Eulji Medical Center (EMC) said Wednesday that it would provide invitation ...
by Lee Han-soo  |  2019-10-16 11:28
라인
Seoul Medical Center transfer public healthcare know-how to developing countries
Seoul Medical Center (SMC) is speeding up the transfer of "Seoul-model publ...
by Lee Han-soo  |  2019-10-15 18:02
여백
여백
여백
Back to Top